An observational study in Itch, sponsored by University Hospital, Basel, Switzerland. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-04-08.
Sponsored by University Hospital, Basel, Switzerland · Observational
This study is to investigate the pruriception (i.e. the perception of the character and intensity of itch), the impact of itch on quality of life, the response to itch and the subjective efficacy and preferences of the different treatment options among patients with different skin diseases. Better insights into these aspects might help to optimize itch treatment in clinical Settings.
354 studies on the registry are indexed under Pruritus; 74 are open to participants now.
This study's enrollment of 300 is above the median of 100 across 43 observational studies indexed under Pruritus.
Browse Pruritus studies →University Hospital, Basel, Switzerland is the lead sponsor of 968 studies on the registry; 191 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All outpatients of the dermatologic university clinic suffering from itch are eligible to participate in the study (from December 2015 until the end of April 2016).
Exclusion Criteria:
self-administered patient questionnaire regarding the different aspects of itch
itch intensity
Questions regarding itch perception (NRS 0-10; 0 = no itch, 10 = worst imaginable itch) experienced at the moment, within the last 7 days, within the last month
Time frame: single time point assessment at baseline
itch perception
Questions regarding situations in which the itch is especially bad (multiple choice options regarding day time, daily situations, season); objective assessment in which respondents are asked to select answers from the choices offered as a list
Time frame: single time point assessment at baseline
impact of itch on quality of life
Questions regarding strength of impact of itch on quality of life (NRS 0-10; 0 = no impact, 10 = extreme)
Time frame: single time point assessment at baseline
quality of sleep
Questions regarding sleep disturbance by itch (Does itch disturb the patient's sleep and/or sleep of other persons? (yes/no))
Time frame: single time point assessment at baseline
days missing at work
Approximate number of days missing at work due to itch within last 6 months
Time frame: single time point assessment at baseline
helpfulness of common itch therapies
Questions regarding helpfulness of common itch therapies (NRS 0-10; 0 = no reduction in itch, 10 = complete reduction of itch; additionally free text options to indicate specific creams, tablets or alternative medicine)
Time frame: single time point assessment at baseline
preferred treatment options
Questions regarding preferred treatment options (NRS 0- 10; 0 = unimportant, 10 = most important; including additional free text option)
Time frame: single time point assessment at baseline
This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Basel, Switzerland